Details for Patent: 6,251,912
✉ Email this page to a colleague
Summary for Patent: 6,251,912
Title: | Substituted quinazoline derivatives |
Abstract: | This invention provides compounds of formula 1 having the structure ##STR1## wherein: X, R.sub.1, R.sub.2, R.sub.3, R.sub.4, Z, X, and n are as defined hereinbefore in the specification, which are useful as antineoplastic agents and in the treatment of certain kidney diseases, such as polycystic kidney disease. |
Inventor(s): | Wissner; Allan (Ardsley, NY), Tsou; Hwei-Ru (New City, NY), Johnson; Bernard D. (Stony Point, NY), Hamann; Philip R. (Garnerville, NY), Zhang; Nan (Suffern, NY) |
Assignee: | American Cyanamid Company (Madison, NJ) |
Application Number: | 09/124,365 |
Patent Claim Types: see list of patent claims | Compound; Use; Composition; |
Drugs Protected by US Patent 6,251,912
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |